Special Issue on SARS-CoV-2 (CoVID-19)
An outbreak of pneumonia was erupted in Chinese seafood market in Wuhan during late 2019 and within a month of its origin, on 30 January 2020, a Public Health Emergency of International Concern was declared by the World Health Organization (WHO) due to its high human-to-human transmission. Within next month, the outbreak of coronavirus disease in 2019 (CoVID-19) soared among communities unprecedentedly and spread across the globe and a pandemic was declared on 11 March 2020 by WHO. Since then, efforts are being made to fast tract vaccines, therapeutics and invent novel control strategies.
The primary objective of special issue is to collate critical thinking, innovative proposals and to forge international collaboration to tackle this contagion. Therefore, we invite original articles, critical reviews and expert commentaries on all aspects of SARS-CoV-2 and CoVID-19, including but not limited to:
• Evolution and Epidemiology
• Host-Pathogen Interactions – Virulence and Pathogenicity
• Pathogen Mechanisms of Immune Evasion
• Next Generation Disease Control Strategies
• Vaccines
• Immunity
• Diagnostics
• Zoonoses and Socio-economic impacts
• Global Research Opportunities and Threats
Briefs on Special Issue:
Deadline: 23 December 2020
Publication: soon after acceptance
Processing charges: none (free for authors and free to read)
Submission: online using
following link (please choose "Special Issue: CoVID-19" as field of research during online submission) or through email at
alizohaib7@hotmail.com
Special issue Editor:
Dr. Ali Zohaib
Assistant Professor (Virology)
Department of Healthcare Biotechnology
Atta-ur-Rahman School of Applied Biosciences (ASAB),
National University of Sciences and Technology (NUST)
Academic Block-1, Main NUST Campus,
Sector: H-12, ISLAMABAD, Pakistan
Email: alizohaib7@hotmail.com